Company intelligence / Profile preview
Cerus Corporation
Concord, California, United Statescerus.com ↗
- Ownership
- Private
- Employees
- ~254
- Development stage
- Commercial
01
Overview
Cerus’ INTERCEPT Blood System for platelets and plasma has both FDA and CE Mark approval and is commercially available globally. The system for cryoprecipitation (INTERCEPT Fibrinogen Complex) is approved in the US. The red blood cell system remains in late-stage clinical development with ongoing regulatory submissions in the US and Europe. Recent BARDA funding supports further development and potential commercialization of the RBC product.
- Therapeutic areas
- Infectious DiseasesHematology
- Modalities
- DeviceBiologic (blood components)Pathogen reduction technology
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
16 assets15 more assets in the full pipeline.
03
Partnerships
Fresenius Kabi – manufacturing partner for device setsTerumo BCT – strategic collaboration to expand adoption of Intercept platformGrifols S.A. – commercialization agreement for Spain & Portugal markets historicallyBARDA – U.S. government funding partner supporting RBC program development
04
Financials
- Market cap
- $430.2M
- Total revenue
- $206.1M
- Enterprise value
- $448M
Beyond the preview
Go deeper on Cerus Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cerus Corporation.